OFM
SYRS

Omega Fund Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Omega Fund Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-251,270
Closed -$57.8K – 14
2024
Q4 		$57.8K Hold
251,270
– – 0.04% 12
2024
Q3 		$540K Hold
251,270
– – 0.34% 11
2024
Q2 		$1.3M Hold
251,270
– – 0.96% 10
2024
Q1 		$1.34M Hold
251,270
– – 0.87% 10
2023
Q4 		$1.96M Hold
251,270
– – 1.59% 12
2023
Q3 		$993K Hold
251,270
– – 0.91% 11
2023
Q2 		$792K Hold
251,270
– – 0.44% 11
2023
Q1 		$671K Hold
251,270
– – 0.44% 12
2022
Q4 		$902K Hold
251,270
– – 0.3% 14
2022
Q3 		$1.62M Sell
251,270
-1
-0% -$8 0.59% 16
2022
Q2 		$2.42M Hold
251,271
– – 0.77% 17
2022
Q1 		$2.99M Hold
251,271
– – 0.61% 19
2021
Q4 		$8.19M Hold
251,271
– – 1.16% 16
2021
Q3 		$11.2M Buy
251,271
+23,788
+10% +$1.16M 1.26% 16
2021
Q2 		$12.4M Buy
227,483
+71,233
+46% +$4.22M 1.4% 13
2021
Q1 		$11.7M Hold
156,250
– – 1.11% 15
2020
Q4 		$17M Buy
+156,250
New +$14.3M 2.54% 10

Other funds holding SYRS

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Omega Fund Management's SYRS Position: Q1 2025 in Review

Omega Fund Management sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2025, closing a stake of 251,270 shares — an estimated $57.8K sold.

Omega Fund Management first reported a position in SYRS in Q4 2020 and held it in 17 quarters. The position peaked at $17M in Q4 2020. 7 funds tracked by Wall St. Rank hold SYRS as of Q1 2025.

  • Omega Fund Management reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Omega Fund Management sold 251,270 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $57.8K.
  • Omega Fund Management first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • Omega Fund Management's Syros Pharmaceuticals, Inc. Common Stock position peaked at $17M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on Omega Fund Management's 13F filing for Q1 2025, filed 15 May 2025.